A group of European experts was commissioned to establish guidelines on the therapeutic
use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until …

Hypokinetic dysarthria (HD) occurs in 90% of Parkinson's disease (PD) patients. It manifests
specifically in the areas of articulation, phonation, prosody, speech fluency, and faciokinesis …

Background Hypokinetic dysarthria is a common but difficult-to-treat symptom of Parkinson's
disease (PD). Objectives We evaluated the long-term effects of multiple-session repetitive …

Dementia is a devastating condition, with profound cognitive changes affecting every aspect
of an individual's functioning. The loss of communication is one symptom above others that …

Repetitive transcranial magnetic stimulation (rTMS) is emerging as a valuable adjunctive
therapeutic modality in movement disorders. It is a non-invasive technique of repeated …

Background Although non-invasive central and peripheral stimulations are accruing support
as promising treatments in different neurological conditions, their effects on dysarthria have …

BACKGROUND: Transcranial magnetic stimulation (TMS) has been used in both
physiological studies and, more recently, the therapy of Parkinson's Disease (PD). Prior TMS …

Measures of performance rates in speech-like or volitional nonspeech oral motor tasks are
frequently used to draw inferences about articulation rate abnormalities in patients with …

Accumulating evidence suggests that impairment in auditory-vocal integration characterized
by abnormally enhanced vocal compensations for auditory feedback perturbations …

Transcranial magnetic stimulation (TMS) has emerged as a novel technique to stimulate the
human brain through the scalp. Over the years, identifying the optimal brain region and …